| Pyrrolopyrimidine CDK4/6 coreAbstract pharmacophorepyrrolopyrimidine-cdk-corePage | Scaffold | c1cc2c(ncnc2nc1N)N | — | — | CDK4/6 · core · Shared pharmacophore / core scaffold. Anchor for the CDK4/6 inhibitor chemical series line… |
| Abemaciclib (Verzenio)Verified drugabemaciclibPage | Drug | CC1=CC(=CC=C1)C2=CN=C(N3CCN(CC3)CC4=CC=C(C… | Pyrrolopyrimidine CDK4/6 core | 7%iStructural similarity calculated using Morgan fingerprint (RDKit circular fingerprint, radius 2, 2048 bits) with Tanimoto similarity. Structural similarity does not predict biological equivalence, potency, safety, or clinical efficacy. | approved · CDK4/6 · Approved therapeutic. Abemaciclib (Verzenio) in this family map. · CHEMBL3301612 · CID 46220502 |
| Palbociclib (Ibrance)Verified drugpalbociclibPage | Drug | CC1=CC(=CC(=C1)C2=NC3=C(C=C(C=C3)N(C)C)N=C… | Pyrrolopyrimidine CDK4/6 core | 14%iStructural similarity calculated using Morgan fingerprint (RDKit circular fingerprint, radius 2, 2048 bits) with Tanimoto similarity. Structural similarity does not predict biological equivalence, potency, safety, or clinical efficacy. | approved · CDK4/6 · CDK4/6 inhibitor combined with endocrine therapy. · CHEMBL189963 · CID 5330286 |
| Ribociclib (Kisqali)Verified drugribociclibPage | Drug | COc1cccc(N2CCN(CC2)c3nc(-c4cn(C)c5ncnc(N)c… | Pyrrolopyrimidine CDK4/6 core | — | approved · CDK4/6 · Approved therapeutic. Ribociclib (Kisqali) in this family map. · CHEMBL3545110 · CID 44631912 |
| CDK amide-extended analogExploratory analog (rule-generated)cdk-sar-amidePage | Derivative | CC1=CC(=CC(=C1)C2=NC3=C(C=C(C=C3)N(C)C)N=C… | CDK SAR piperazine analog | 13%iStructural similarity calculated using Morgan fingerprint (RDKit circular fingerprint, radius 2, 2048 bits) with Tanimoto similarity. Structural similarity does not predict biological equivalence, potency, safety, or clinical efficacy. | SAR · ADME · SAR exploration node. Derived analog of parent node in CDK4/6 inhibitor chemical series. |
| CDK SAR piperazine analogExploratory analog (rule-generated)cdk-sar-piperazinePage | Derivative | CC1=CC(=CC(=C1)C2=NC3=C(C=C(C=C3)N(C)C)N=C… | Palbociclib (Ibrance) | 14%iStructural similarity calculated using Morgan fingerprint (RDKit circular fingerprint, radius 2, 2048 bits) with Tanimoto similarity. Structural similarity does not predict biological equivalence, potency, safety, or clinical efficacy. | SAR · SAR exploration node. Derived analog of parent node in CDK4/6 inhibitor chemical series. |